Ocaliva is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Intercept Pharmaceuticals Inc. The primary component is Obeticholic Acid.
| Product ID | 69516-010_1d6c9e9d-e17d-4609-91fa-75e5bdbc5114 |
| NDC | 69516-010 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ocaliva |
| Generic Name | Obeticholic Acid |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-05-27 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207999 |
| Labeler Name | Intercept Pharmaceuticals Inc |
| Substance Name | OBETICHOLIC ACID |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Farnesoid X Receptor Agonist [EPC], Farnesoid X Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2016-05-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA207999 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-05-27 |
| Ingredient | Strength |
|---|---|
| OBETICHOLIC ACID | 10 mg/1 |
| SPL SET ID: | cdfbe0cd-eb15-45a1-ac17-531bcda21aec |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69516-005 | Ocaliva | Obeticholic Acid |
| 69516-010 | Ocaliva | Obeticholic Acid |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OCALIVA 86710924 5033038 Live/Registered |
INTERCEPT PHARMACEUTICALS, INC. 2015-07-31 |
![]() OCALIVA 86710865 5014396 Live/Registered |
INTERCEPT PHARMACEUTICALS, INC. 2015-07-31 |